Adenosine

Adenosine

SCHEMBL5981999

NC(=O)c1cccnc1.Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.O=P(O)(O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3

The experimentally established mechanism targets of Adenosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 known ✓ P30542 4/20 0.65
ADORA3 known ✓ P0DMS8 4/20 0.65
ADORA2A known ✓ P29274 2/20 0.65
ADORA2B known ✓ P29275 1/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
DPP4 P27487 1/20 0.65
MEN1 O00255 1/20 0.65
SLC28A1 O00337 1/20 0.65
MAP3K7 O43318 1/20 0.65
SLC28A2 O43868 1/20 0.65
GAPDH P04406 1/20 0.65
MAPK1 P28482 1/20 0.65
STAT6 P42226 1/20 0.65
PI4KA P42356 1/20 0.65
KMT2A Q03164 1/20 0.65
PI4K2B Q8TCG2 1/20 0.65
DOT1L Q8TEK3 1/20 0.65
SLC29A1 Q99808 1/20 0.65
PI4K2A Q9BTU6 1/20 0.65
SLC28A3 Q9HAS3 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine SCHEMBL560740 0.97 ADORA3 (0.70) ADORA1ADORA3SMN1; SMN2ADORA2ADPP4
Adenosine SCHEMBL28391361 0.97 ADORA3 (0.70) ADORA1ADORA3SMN1; SMN2ADORA2ADPP4
Adenosine SCHEMBL6803120 0.93 ADORA1 (0.65) ADORA1ADORA3SMN1; SMN2ADORA2ADPP4
Niacinamide SCHEMBL28249016 0.90 ADH1A (0.66) SMN1; SMN2ADH1AIMPDH2NADKIMPDH1
Adenosine Phosphate SCHEMBL160972 0.90 P2RY1 (0.75) ADORA1SMN1; SMN2ADH1AIMPDH2NADK
Adenosine Phosphate SCHEMBL27419541 0.90 P2RY1 (0.75) ADORA1SMN1; SMN2ADH1AIMPDH2NADK
Adenosine SCHEMBL11028276 0.89 ADORA3 (0.68) ADORA1ADORA3SMN1; SMN2ADORA2ADPP4
Adenosine Diphosphate SCHEMBL570243 0.87 ADH1A (0.74) SMN1; SMN2ADH1AIMPDH2NADKIMPDH1
Adenosine SCHEMBL3296155 0.87 ADORA3 (0.83) ADORA1ADORA3SMN1; SMN2ADORA2ADPP4
Adenosine Triphosphate SCHEMBL811698 0.86 ADH1A (0.75) SMN1; SMN2ADH1AIMPDH2NADKIMPDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040156873-A1 Topically Bioavailable Acne and Rosacea Treatment Compositions GUPTA SHYAM K (US) 2004-08-12 US claimed
US-20040081672-A1 Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging GUPTA SHYAM K (US) 2004-04-29 US claimed
US-10173942-B2 Non-corrosive nitrification inhibitor polar solvent formulation DOW AGROSCIENCES, LLC (US) 2019-01-08 US disclosed
US-10173943-B2 Non-corrosive nitrification inhibitor polar solvent formulation DOW AGROSCIENCES, LLC (US) 2019-01-08 US disclosed
WO-2017069828-A1 NON-CORROSIVE NITRIFICATION INHIBITOR POLAR SOLVENT FORMULATION DOW AGROSCIENCES, LLC (US) 2017-04-27 WO disclosed
WO-2017069827-A1 NON-CORROSIVE NITRIFICATION INHIBITOR POLAR SOLVENT FORMULATION DOW AGROSCIENCES, LLC (US) 2017-04-27 WO disclosed
US-20160332930-A1 NON-CORROSIVE NITRIFICATION INHIBITOR POLAR SOLVENT FORMULATION SPECIALTY OPERATIONS FRANCE (FR) 2016-11-17 US disclosed
US-20160332931-A1 NON-CORROSIVE NITRIFICATION INHIBITOR POLAR SOLVENT FORMULATION SPECIALTY OPERATIONS FRANCE (FR) 2016-11-17 US disclosed
WO-2006023710-A2 COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN CARE INFINITY2 HEALTH SCIENCES, INC. (US) 2006-03-02 WO disclosed
US-20060039887-A1 Cosmetic or pharmaceutical composition for skin care INFINITY2 HEALTH SCIENCES, INC. 2006-02-23 US disclosed
US-20040228884-A1 Ion-pair delivery system for cosmetic and pharmaceutical compositions GUPTA SHYAM K (US) 2004-11-18 US disclosed